95 related articles for article (PubMed ID: 31634418)
1. Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment.
Yu H; Shi Z; Lin X; Bao Q; Jia H; Wei J; Helfand BT; Zheng SL; Duggan D; Lu D; Mo Z; Xu J
Prostate; 2020 Jan; 80(1):83-87. PubMed ID: 31634418
[TBL] [Abstract][Full Text] [Related]
2. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
Yu H; Shi Z; Wu Y; Wang CH; Lin X; Perschon C; Isaacs WB; Helfand BT; Lilly Zheng S; Duggan D; Mo Z; Lu D; Xu J
Prostate; 2019 Jul; 79(10):1099-1105. PubMed ID: 31037745
[TBL] [Abstract][Full Text] [Related]
3. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
4. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Wu Y; Ruan X; Gao P; Da H; Fang Z; Xu D; Jiang H; Ding Q; Lin X; Lu D; Na R
Clin Genet; 2023 Jun; 103(6):636-643. PubMed ID: 36840471
[TBL] [Abstract][Full Text] [Related]
6. Clinical validity and utility of genetic risk scores in prostate cancer.
Helfand BT; Kearns J; Conran C; Xu J
Asian J Androl; 2016; 18(4):509-14. PubMed ID: 27297129
[TBL] [Abstract][Full Text] [Related]
7. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J
Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965
[TBL] [Abstract][Full Text] [Related]
8. Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.
Wei J; Shi Z; Na R; Resurreccion WK; Wang CH; Duggan D; Zheng SL; Hulick PJ; Helfand BT; Xu J
J Med Genet; 2022 Mar; 59(3):243-247. PubMed ID: 33443076
[TBL] [Abstract][Full Text] [Related]
9. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Chen H; Na R; Packiam VT; Conran CA; Jiang D; Tao S; Yu H; Lin X; Meng W; Zheng SL; Brendler CB; Helfand BT; Xu J
Prostate; 2017 Aug; 77(11):1179-1186. PubMed ID: 28670847
[TBL] [Abstract][Full Text] [Related]
10. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.
Wu C; Zhu J; King A; Tong X; Lu Q; Park JY; Wang L; Gao G; Deng HW; Yang Y; Knudsen KE; Rebbeck TR; Long J; Zheng W; Pan W; Conti DV; Haiman CA; Wu L
Cancer Commun (Lond); 2021 Dec; 41(12):1387-1397. PubMed ID: 34520132
[TBL] [Abstract][Full Text] [Related]
11. Detection of gene-environment interactions in the presence of linkage disequilibrium and noise by using genetic risk scores with internal weights from elastic net regression.
Hüls A; Ickstadt K; Schikowski T; Krämer U
BMC Genet; 2017 Jun; 18(1):55. PubMed ID: 28606108
[TBL] [Abstract][Full Text] [Related]
12. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases.
Na R; Ye D; Qi J; Liu F; Lin X; Helfand BT; Brendler CB; Conran C; Gong J; Wu Y; Gao X; Chen Y; Zheng SL; Mo Z; Ding Q; Sun Y; Xu J
Asian J Androl; 2016; 18(4):525-9. PubMed ID: 27140652
[TBL] [Abstract][Full Text] [Related]
13. A comparison of genetic risk score with family history for estimating prostate cancer risk.
Helfand BT
Asian J Androl; 2016; 18(4):515-9. PubMed ID: 27004541
[TBL] [Abstract][Full Text] [Related]
14. [Genetic risk score: principle, methods and application].
Wang C; Dai J; Sun Y; Xie L; Pan L; Hu Z; Shen H
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Oct; 36(10):1062-4. PubMed ID: 26837344
[TBL] [Abstract][Full Text] [Related]
15. Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Shi Z; Yu H; Wu Y; Lin X; Bao Q; Jia H; Perschon C; Duggan D; Helfand BT; Zheng SL; Xu J
Cancer Med; 2019 Jun; 8(6):3196-3205. PubMed ID: 30968590
[TBL] [Abstract][Full Text] [Related]
16. The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci.
Kisiel B; Kisiel K; Szymański K; Mackiewicz W; Biało-Wójcicka E; Uczniak S; Fogtman A; Iwanicka-Nowicka R; Koblowska M; Kossowska H; Placha G; Sykulski M; Bachta A; Tłustochowicz W; Płoski R; Kaszuba A
PLoS One; 2017; 12(6):e0179348. PubMed ID: 28617847
[TBL] [Abstract][Full Text] [Related]
17. The combined effects of cardiovascular disease related SNPs on ischemic stroke.
Xu K; Liu X; Ott J; Jiang F; Zhang W; Wang L; Zhao J; Wang X
J Neurol Sci; 2018 May; 388():141-145. PubMed ID: 29627009
[TBL] [Abstract][Full Text] [Related]
18. Prediction of individual genetic risk to prostate cancer using a polygenic score.
Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai ZS; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubiński J; Kluźniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lin HY; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; ; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; ; Gronberg H; Wiklund F
Prostate; 2015 Sep; 75(13):1467-74. PubMed ID: 26177737
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk score (GRS) constructed from polymorphisms in the PON1, IL-6, ITGB3, and ALDH2 genes is associated with the risk of coronary artery disease in Pakistani subjects.
Shabana NA; Ashiq S; Ijaz A; Khalid F; Saadat IU; Khan K; Sarwar S; Shahid SU
Lipids Health Dis; 2018 Sep; 17(1):224. PubMed ID: 30261890
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
